<DOC>
	<DOCNO>NCT02308202</DOCNO>
	<brief_summary>The aim study determine effect treatment doxazosin XL 16 mg/d combine virtual reality ( VR ) exposure therapy Post Traumatic Stress Disorder . The effect treatment doxazosin XL 16 mg/d combine virtual reality ( VR ) exposure therapy assess double-blind , placebo-controlled study . The study enroll 30 participant . The investigator use within group design participant receive placebo doxazosin ( N=16 ) order counterbalance across participant . A second group patient ( N=16 ) receive 16mg perindopril placebo instead doxazosin/placebo .</brief_summary>
	<brief_title>DOXAZOSIN FOR PTSD</brief_title>
	<detailed_description />
	<mesh_term>Doxazosin</mesh_term>
	<mesh_term>Perindopril</mesh_term>
	<criteria>1 . Be male OIF/OEF veteran active duty . Males include small pilot study sufficient sample size analyze gender effect . Women include subsequent study 2 . Be age 18 55 year 3 . Meet DSMIV TR criterion PTSD 4 . Meet inclusion criterion VRE participation 5 . Have vital sign follow : supine blood pressure &gt; 100/65 mm Hg , seat blood pressure great 90/60 mm Hg , orthostatic change small than20 mm Hg systolic 10 mm Hg diastolic stand . Participants hypertension ( BP 150/100 ) 6 . Have hematology chemistry laboratory test within reference limit ( ±10 % ) , follow exception : ( ) total bilirubin must less 2x upper limit normal ALT , AST , alkaline phosphatase le 3× upper limit normal ( b ) kidney function test ( creatinine BUN ) within normal limit 7 . Have baseline ECG demonstrate clinically normal sinus rhythm , clinically normal conduction , clinically significant arrhythmias 8 . Have medical history brief physical examination demonstrate clinically significant contraindication study participation , judgment admit physician principal investigator 1 . Have history evidence suggestive seizure disorder brain injury 2 . Have neurological psychiatric disorder , psychosis bipolar illness assess Structural Clinical Interview DSM disorder ( SCID ) ; clinically significant organic brain disease dementia Axis I psychiatric illness PTSD would interfere study ; acceptable history suicide attempt within past year and/or current suicidal ideation/plan 3 . Have evidence untreated unstable medical illness include neuroendocrine , autoimmune , renal , hepatic , active infectious disease 4 . Have HIV currently symptomatic take antiretroviral medication 5 . Have illness condition opinion PI and/or admit physician would preclude safe and/or successful completion study 6 . Dr. Newton ( medical supervisor ) review potential participant ' prescribed medication make final decision eligibility . We anticipate participant wide range medication prescribe PTSD . However , treatment unlikely interact doxazosin effect study . We ask participant change medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>PTSD</keyword>
	<keyword>treatment</keyword>
	<keyword>virtual reality</keyword>
	<keyword>doxazosin</keyword>
</DOC>